Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Eledon Pharmaceuticals In...

    NASDAQ: ELDN · Real-Time Price · USD
    2.97
    -0.06 (-1.98%)
    At close: Jun 05, 2025, 3:59 PM

    Eledon Pharmaceuticals Statistics

    Share Statistics

    Eledon Pharmaceuticals has 59.88M shares outstanding. The number of shares has increased by 55.51% in one year.

    Shares Outstanding

    n/a
    		 59.88M

    Shares Change (YoY)

    n/a
    		 55.51%

    Shares Change (QoQ)

    n/a
    		 0.24%

    Owned by Institutions (%)

    n/a
    		 74.08%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 6,695

    FTD / Avg. Volume

    n/a
    		 3.02%

    Short Selling Information

    The latest short interest is 1.57M, so 2.62% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.57M

    Short % of Shares Out

    n/a
    		 2.62%

    Short % of Float

    n/a
    		 2.92%

    Short Ratio (days to cover)

    n/a
    		 7.92

    Valuation Ratios

    The PE ratio is -5.66 and the forward PE ratio is -3.49. Eledon Pharmaceuticals's PEG ratio is 0.

    PE Ratio

    n/a
    		 -5.66

    Forward PE

    n/a
    		 -3.49

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 3.3

    PB Ratio

    n/a
    		 1.69

    P/FCF Ratio

    n/a
    		 -4.23

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Eledon Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 12.42, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 12.42

    Quick Ratio

    n/a
    		 12.42

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.03

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,139,419.35

    Employee Count

    n/a
    		 31

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 431K

    Effective Tax Rate

    n/a
    		 -1.21%

    Stock Price Statistics

    The stock price has increased by 6.69% in the last 52 weeks. The beta is -0.16, so Eledon Pharmaceuticals's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.16

    52-Week Price Change

    n/a
    		 6.69%

    50-Day Moving Average

    n/a
    		 3.1

    200-Day Moving Average

    n/a
    		 3.6

    Relative Strength Index (RSI)

    n/a
    		 47.73

    Average Volume (20 Days)

    n/a
    		 221,396

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -70.58M

    Net Income

    n/a
    		 -35.32M

    EBITDA

    n/a
    		 -35.39M

    EBIT

    n/a
    		 -35.75M

    Earnings Per Share (EPS)

    n/a
    		 -0.73
    Full Income Statement

    Balance Sheet

    The company has 20.55M in cash and 954K in debt, giving a net cash position of 19.59M.

    Cash & Cash Equivalents

    n/a
    		 20.55M

    Total Debt

    n/a
    		 954K

    Net Cash

    n/a
    		 19.59M

    Retained Earnings

    n/a
    		 -355.59M

    Total Assets

    n/a
    		 161.31M

    Working Capital

    n/a
    		 118.53M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -47.27M and capital expenditures 0, giving a free cash flow of -47.27M.

    Operating Cash Flow

    n/a
    		 -47.27M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -47.27M

    FCF Per Share

    n/a
    		 -0.97
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ELDN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ELDN is $16, which is 428.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $16

    Price Target Difference

    n/a
    		 428.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 5, 2020. It was a backward split with a ratio of 1:18.

    Last Split Date

    n/a
    		 Oct 5, 2020

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:18

    Scores

    Altman Z-Score

    n/a
    		 -1.43

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist